Fillalbin 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate

CAS : 4540-25-4

Ref. 3D-EAA54025

Informations sur le produit

• Nom: Fillalbin 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate
• CAS: 4540-25-4

Description

Fillalbin 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate is a medicinal compound that has shown potential as an anticancer agent. It works by inhibiting kinases, which are enzymes that play a key role in the growth and spread of cancer cells. Fillalbin has been shown to induce apoptosis, or programmed cell death, in human cancer cells. This analog of kinase inhibitors has also been tested on Chinese hamster ovary cells and found to be effective at inhibiting tumor growth. Fillalbin is excreted in urine and may have potential as a diagnostic tool for cancer detection. Its ability to target specific proteins involved in cancer cell growth makes it a promising candidate for future cancer treatments.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 291.34 g/mol
• Formule: C₁₆H₂₁NO₄
• Degré de pureté: Min. 95%